Skip to content
Clinical Trials – home

Dalbavancin: A Long-Acting Antibiotic for Bacterial Infections

5 / 6
trials open to patients / all trials
5+
Countries

In short

Dalbavancin is an innovative antibiotic being studied in clinical trials for treating various bacterial infections. This long-acting medication shows potential for reducing hospital stays and improving patient outcomes across different types of infections. The following article summarizes key findings from recent clinical trials investigating dalbavancin's effectiveness and safety.

At a glance

Drug Name
Dalbavancin (also known as Xydalba or Dalvance)
Drug Class
Lipoglycopeptide antibiotic
Administration
Intravenous infusion
Key Indications
Acute bacterial skin and skin structure infections (ABSSSI), osteoarticular infections, peritonitis, other Gram-positive bacterial infections
Dosing Regimens
Single dose (1500 mg) or multiple doses (e.g., 1000 mg followed by 500 mg a week later)
Potential Benefits
Long-acting nature, reduced hospital stays, improved patient convenience, potential cost savings
Ongoing Research
Efficacy in various infections, use in special populations (e.g., infants, diabetics), hospital avoidance strategies
Safety Profile
Generally well-tolerated, but further research needed in diverse patient populations

What is Dalbavancin?

Dalbavancin is a powerful antibiotic used to treat certain types of bacterial infections. It belongs to a class of drugs called lipoglycopeptides, which are designed to fight against gram-positive bacteria. These are a specific type of bacteria that can cause serious infections. Dalbavancin is also known by its brand names Xydalba® and Dalvance®.

How Does Dalbavancin Work?

Dalbavancin works by attacking the cell walls of gram-positive bacteria, which ultimately leads to their death. What makes dalbavancin unique is its long-lasting effect in the body. Unlike many other antibiotics that require daily doses, dalbavancin can remain active in the body for an extended period, allowing for less frequent dosing.

What Conditions Does Dalbavancin Treat?

Dalbavancin is primarily used to treat the following conditions:

  • Acute Bacterial Skin and Skin Structure Infections (ABSSSI): These are serious skin infections that can involve deeper layers of skin and surrounding tissues.
  • Gram-positive bacteremia: This is a condition where bacteria are present in the bloodstream.
  • Osteoarticular infections: These are infections affecting bones and joints, particularly those associated with hip and knee replacements.
  • Peritonitis: An infection of the abdominal lining, particularly in patients undergoing peritoneal dialysis.

How is Dalbavancin Administered?

Dalbavancin is given as an intravenous (IV) infusion, which means it's delivered directly into the bloodstream through a vein. The dosing schedule can vary depending on the specific condition being treated, but generally, it involves one or two doses given over a period of 1-2 weeks. For example:

  • A single dose of 1500 mg
  • Two doses: 1000 mg on day 1, followed by 500 mg on day 8

This unique dosing schedule is one of the key advantages of dalbavancin.

Benefits of Dalbavancin

Dalbavancin offers several benefits over traditional antibiotics:

  1. Convenience: Its long-acting nature means fewer doses are needed, which can reduce hospital stays and allow for outpatient treatment.
  2. Improved compliance: With fewer doses, patients are more likely to complete their full course of treatment.
  3. Reduced risk of infection: Less frequent IV access can lower the risk of catheter-related infections.
  4. Cost-effective: By potentially reducing hospital stays, dalbavancin may lead to overall cost savings in healthcare.

Ongoing Research and Future Applications

Researchers are continually exploring new uses for dalbavancin. Some areas of ongoing research include:

  • Treatment of infections in people who use drugs (PWUD), where maintaining IV access for traditional antibiotics can be challenging.
  • Use in pediatric patients, including infants and neonates with suspected bacterial infections.
  • Treatment of infections in diabetic patients.

Potential Side Effects

Like all medications, dalbavancin can cause side effects. Common side effects may include:

  • Nausea
  • Headache
  • Diarrhea

More serious side effects are rare but can occur. It's important to discuss potential risks and benefits with your healthcare provider.

Questions people often ask

Conditions where Dalbavancin is being studied

Each condition opens its own overview and trial list

Trials with Dalbavancin

Recruiting trials first

See all 6 →
Quick filters
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.